Given that dysregulated autophagy contributes to cancer cell survival and resistance to therapy, further elucidation of the role of A20 in autophagy regulation may offer novel insights into its potential as a therapeutic target in cancer. The gene discussed is TNFAIP3; the disease is cancer.